Identifying Peach and Plum Polyphenols with Chemopreventive Potential against Estrogen-Independent Breast Cancer Cells

被引:129
|
作者
Noratto, Giuliana [1 ,2 ]
Porter, Weston
Byrne, David [1 ,2 ]
Cisneros-Zevallos, Luis [1 ,2 ]
机构
[1] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA
[2] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA
关键词
Breast cancer; peaches; plums; chlorogenic acid; neo-chlorogenic acid; CHLOROGENIC ACID; PHENOLIC-COMPOUNDS; PHYTOCHEMICALS; CYTOTOXICITY; MECHANISMS;
D O I
10.1021/jf900259m
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Our objective was to evaluate the cancer suppression activity of extracts from a commercial variety of yellow-fleshed peach 'Rich Lady' (RL) and a red-fleshed plum 'Black Splendor' (BS) and identify the phenolic fractions that may possess potential as chemopreventive and/or chemotherapeutic natural compounds. The peach RL extract effectively inhibited the proliferation of the estrogen-independent MDA-MB-435 breast cancer cell line. The concentration to inhibit 50% of cell proliferation (IC50) was similar to 42 mg/L for-this cell line compared to an IC50 of similar to 130 and similar to 515 mg/L for the noncancerous breast cell line MCF-10A and the estrogen-dependent breast cancer cell line MCF-7, respectively. Similarly, BS extracts showed greater effects on MDA-MB-435 cells as compared to the other breast cancer or the normal breast cell lines. In general, BS extracts were less effective than RL extracts. Within all RL and BS fractions, fraction 3 (F3, flavonoids) and fraction 4 (F4, procyanidins) were more potent than fraction 1 (F1, phenolic acids) and fraction 2 (F2, anthocyanins) against the three cell lines. The order of potency of RL fractions against MDA-MB-435 was F-3 similar to F-4 > F-1 > F-2. The antiproliferative activity of pure compounds identified in F-3 and F-1 confirmed that quercetin 3 beta-glucoside is the bioactive compound in F-3, with the same level of toxicity on the estrogen-independent MDA-MB-435 breast cancer and breast epithelial MCF-10A cells (IC50 = 1.9 +/- 0.2 and 1.8 +/- 0.3, respectively). However, we confirmed that phenolic acids present in F-1: chlorogenic and neo-chlorogenic acids have potential as chemopreventive dietary compounds because of the relatively high growth inhibition exerted on the estrogen-independent MDA-MB-435 breast cancer cell line and low toxicity exerted in the normal MCF-10A cells.
引用
收藏
页码:5219 / 5226
页数:8
相关论文
共 50 条
  • [2] NF-κB is a crucial regulator of estrogen-independent growth of breast cancer cells
    Oida, K.
    Matsuda, A.
    Itai, A.
    Jensen-Jarolim, E.
    Ohmori, K.
    Matsuda, H.
    Tanaka, A.
    ALLERGY, 2012, 67 : 640 - 640
  • [3] Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
    Cheng Jiang
    Junming Guo
    Zhe Wang
    Bingxiu Xiao
    Hyo-Jung Lee
    Eun-Ok Lee
    Sung-Hoon Kim
    Junxuan Lu
    Breast Cancer Research, 9
  • [4] EFFECTS OF TAMOXIFEN ON GROWTH AND APOPTOSIS OF ESTROGEN-DEPENDENT AND ESTROGEN-INDEPENDENT HUMAN BREAST-CANCER CELLS
    PERRY, RR
    KANG, Y
    GREAVES, B
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (03) : 238 - 245
  • [5] Role of cMYC as a critical determinant of estrogen-independent growth of estrogen deprivation-resistant breast cancer cells
    Sengupta, Surojeet
    Biarnes, Michael C.
    Jordan, V. Craig
    CANCER RESEARCH, 2012, 72
  • [6] Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
    Jiang, Cheng
    Guo, Junming
    Wang, Zhe
    Xiao, Bingxiu
    Lee, Hyo-Jung
    Lee, Eun-Ok
    Kim, Sung-Hoon
    Lu, Junxuan
    BREAST CANCER RESEARCH, 2007, 9 (06):
  • [7] Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells
    Lilling, G
    Nordenberg, J
    Rotter, V
    Goldfinger, N
    Peller, S
    Sidi, Y
    CANCER INVESTIGATION, 2002, 20 (04) : 509 - 517
  • [8] Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells
    Sarvilinna, N
    Eronen, H
    Miettinen, S
    Vienonen, A
    Ylikomi, T
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 832 - 840
  • [9] Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth
    Jieying Zhao
    Guangchun Chen
    Dongmei Cao
    Yidong Li
    Fei Diao
    Haoyu Cai
    Yiduo Jin
    Jian Lu
    Breast Cancer Research and Treatment, 2010, 119 : 39 - 51
  • [10] Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth
    Zhao, Jieying
    Chen, Guangchun
    Cao, Dongmei
    Li, Yidong
    Diao, Fei
    Cai, Haoyu
    Jin, Yiduo
    Lu, Jian
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 39 - 51